AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Appili Therapeutics Inc.

CAD 0.01 -$0.02 (-60.00%)
TSX · 11 Sep 2026 20:10 UTC
Previous Close
CAD 0.01
Day Range
CAD 0.01 - CAD 0.01
Year Range
CAD 0.01CAD 0.04
Market Cap
1.32M
AVG Volume
56.6K
Trailing/Forward PE
-0.28/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Toronto Stock ExchangeCA
Revenue (CAD)
-50K050K100K150K24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Revenue (CAD) by quarter
PeriodRevenue (CAD)
27 Q1117.89K
26 Q442K
26 Q3114.98K
26 Q2103.94K
26 Q10
25 Q4-12.61K
25 Q3108.36K
25 Q24.69K
25 Q10
24 Q411.7K
Net Income (CAD)
-2M-1.5M-1M-500K0500K24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Net Income (CAD) by quarter
PeriodNet Income (CAD)
27 Q1-1.7M
26 Q4-1.04M
26 Q3-949.5K
26 Q2-989.07K
26 Q1-1.25M
25 Q4228.05K
25 Q3-524.34K
25 Q2-743.49K
25 Q1-1.58M
24 Q4-1.1M
Operating Income (CAD)
-3M-2M-1M01M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
27 Q1-1.61M
26 Q4-2.45M
26 Q3-717.31K
26 Q2-1.3M
26 Q1-1.05M
25 Q4-61.8K
25 Q3497.07K
25 Q2-329.01K
25 Q1-3
24 Q4-2.42M
EBITDA (CAD)
-3M-2M-1M01M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
27 Q1-1.61M
26 Q4-2.45M
26 Q3-717.44K
26 Q2-1.07M
26 Q1-729.04K
25 Q4928.45K
25 Q3-8.21K
25 Q2-209.23K
25 Q1-350.44K
24 Q4-708.36K
Cash Flows (CAD)
-1M-500K0500K1M1.5M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
27 Q10
26 Q4-264.97K
26 Q3-293.07K
26 Q2-759.38K
26 Q1-6.36K
25 Q41.03M
25 Q3-443.07K
25 Q2407.37K
25 Q1-132.07K
24 Q4-473.73K
EPS (CAD)
-0.01-0.01-000.0124 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO EPS (CAD) by quarter
PeriodEPS (CAD)
27 Q1-0.01
26 Q4-0.01
26 Q3-0.01
26 Q2-0.01
26 Q1-0.01
25 Q40
25 Q3-0
25 Q2-0.01
25 Q1-0.01
24 Q4-0.01
Expenses (CAD)
-1M01M2M3MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Expenses (CAD) by quarter
PeriodExpenses (CAD)
27 Q11.69M
26 Q42.5M
26 Q3832.29K
26 Q21.4M
26 Q11.6M
25 Q42.52M
25 Q32.16M
25 Q22.71M
25 Q12.78M
24 Q42.43M
Cash & Debt (CAD)
05M10M15MCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
27 Q1138.68K
26 Q440K
26 Q3212.75K
26 Q2348.68K
26 Q11.13M
25 Q41.23M
25 Q3186.17K
25 Q2665.22K
25 Q1301.26K
24 Q494.49K
Debt ratios
-800-600-400-200020024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Debt ratios by quarter
PeriodDebt ratios
27 Q1-2.25
26 Q4-2.59
26 Q3-7.7
26 Q2-13.48
26 Q1-622.56
25 Q430.69
25 Q3-8.7
25 Q2-10.04
25 Q1-7.7
24 Q4-3.91
Margins
0%50%100%150%24 Q224 Q324 Q425 Q225 Q325 Q426 Q226 Q326 Q427 Q1
APLI.TO Margins by quarter
PeriodMargins
27 Q198.85%
26 Q496.78%
26 Q3100.11%
26 Q296.88%
25 Q4100%
25 Q396.24%
25 Q2100%
24 Q472.48%
24 Q399.29%
24 Q298.98%
Return on Capital
-5%0%5%10%15%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Return on Capital by quarter
PeriodReturn on Capital
27 Q18.93%
26 Q46.03%
26 Q35.79%
26 Q26.34%
26 Q18.54%
25 Q4-1.7%
25 Q33.85%
25 Q25.67%
25 Q112.8%
24 Q410.1%
Shares Outstanding
050M100M150M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Shares Outstanding by quarter
PeriodShares Outstanding
27 Q1132.37M
26 Q4132.37M
26 Q3128.37M
26 Q2121.27M
26 Q1121.27M
25 Q4121.27M
25 Q3121.27M
25 Q2121.27M
25 Q1121.27M
24 Q4121.27M
Book Value Per Share (CAD)
-0.15-0.1-0.05-024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
27 Q1-0.14
26 Q4-0.13
26 Q3-0.13
26 Q2-0.13
26 Q1-0.12
25 Q4-0.11
25 Q3-0.11
25 Q2-0.11
25 Q1-0.1
24 Q4-0.09
Total Assets (CAD)
01M2M3M4M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
27 Q11.3M
26 Q41.97M
26 Q3547.91K
26 Q2754.46K
26 Q11.9M
25 Q43.03M
25 Q32.09M
25 Q21.55M
25 Q12.23M
24 Q41.49M
Free Cash Flow Yield
-150%-100%-50%0%50%med -1.28%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
APLI.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-100.01%
Sep 26-100.01%
Aug 26-66.67%
Aug 26-66.67%
Aug 26-100.01%
Aug 26-100.01%
Jul 26-66.67%
Jul 26-100.01%
Jul 26-66.67%
Jul 26-66.67%
Jul 26-66.67%
Jun 26-1.28%
Jun 26-1.28%
Jun 26-1.28%
Jun 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-0.96%
Apr 26-1.28%
Apr 26-1.28%
Apr 26-1.28%
Apr 26-0.96%
Mar 26-7.2%
Mar 26-9.6%
Mar 26-7.2%
Mar 26-7.2%
Feb 26-9.6%
Feb 26-7.2%
Feb 26-7.2%
Feb 26-5.76%
Jan 26-5.76%
Jan 26-7.2%
Jan 26-7.2%
Jan 26-7.2%
Jan 26-5.76%
Dec 2532.73%
Dec 2540.91%
Dec 2532.73%
Dec 2532.73%
Nov 2532.73%
Nov 2532.73%
Nov 2532.73%
Nov 2532.73%
Oct 2532.73%
Oct 2527.27%
Oct 2527.27%
Oct 2532.73%
Oct 2527.27%
Sep 2535.73%
Sep 2547.63%
Sep 2547.63%
Sep 2547.63%
Aug 2535.73%
Aug 2535.73%
Aug 2547.63%
Aug 2535.73%
Aug 2535.73%
Jul 2547.63%
Jul 2547.63%
Jul 2547.63%
Jul 2547.63%
Jun 25-35.27%
Jun 25-35.27%
Jun 25-35.27%
Jun 25-35.27%
May 25-35.27%
May 25-35.27%
May 25-17.63%
May 25-17.63%
May 25-15.11%
Apr 25-17.63%
Apr 25-17.63%
Apr 25-17.63%
Apr 25-17.63%
Mar 251.13%
Mar 251.29%
Mar 251.51%
Mar 251.29%
Feb 251.29%
Feb 251.51%
Feb 251.51%
Feb 251.29%
Jan 251.29%
Jan 251.51%
Jan 251.29%
Jan 251.29%
Jan 251.29%
Dec 24-13.89%
Dec 24-13.89%
Dec 24-12.16%
Dec 24-13.89%
Nov 24-13.89%
Nov 24-13.89%
Nov 24-13.89%
Nov 24-12.16%
Nov 24-13.89%
Oct 24-13.89%
Oct 24-12.16%
Price to Sales
010203040med 12.15Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
APLI.TO Price to Sales by quarter
PeriodPrice to Sales
Sep 265.07
Sep 265.07
Aug 267.61
Aug 267.61
Aug 265.07
Aug 265.07
Jul 267.61
Jul 265.07
Jul 267.61
Jul 267.61
Jul 267.61
Jun 269.33
Jun 269.33
Jun 269.33
Jun 269.33
May 269.33
May 269.33
May 269.33
May 269.33
May 2612.44
Apr 269.33
Apr 269.33
Apr 269.33
Apr 2612.44
Mar 2612.15
Mar 269.11
Mar 2612.15
Mar 2612.15
Feb 269.11
Feb 2612.15
Feb 2612.15
Feb 2615.18
Jan 2615.18
Jan 2612.15
Jan 2612.15
Jan 2612.15
Jan 2615.18
Dec 2530.18
Dec 2524.15
Dec 2530.18
Dec 2530.18
Nov 2530.18
Nov 2530.18
Nov 2530.18
Nov 2530.18
Oct 2530.18
Oct 2536.22
Oct 2536.22
Oct 2530.18
Oct 2536.22
Sep 2524.15
Sep 2518.11
Sep 2518.11
Sep 2518.11
Aug 2524.15
Aug 2524.15
Aug 2518.11
Aug 2524.15
Aug 2524.15
Jul 2518.11
Jul 2518.11
Jul 2518.11
Jul 2518.11
Jun 2514.58
Jun 2514.58
Jun 2514.58
Jun 2514.58
May 2514.58
May 2514.58
May 2529.16
May 2529.16
May 2534.02
Apr 2529.16
Apr 2529.16
Apr 2529.16
Apr 2529.16
Mar 259.8
Mar 258.58
Mar 257.35
Mar 258.58
Feb 258.58
Feb 257.35
Feb 257.35
Feb 258.58
Jan 258.58
Jan 257.35
Jan 258.58
Jan 258.58
Jan 258.58
Dec 245.13
Dec 245.13
Dec 245.86
Dec 245.13
Nov 245.13
Nov 245.13
Nov 245.13
Nov 245.86
Nov 245.13
Oct 245.13
Oct 245.86
EV/EBITDA
35.53636.53737.5med 35.74Jul 25Jul 25Aug 25Aug 25Aug 25Sep 25Sep 25
APLI.TO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2537.42
Sep 2535.74
Sep 2535.74
Sep 2535.74
Aug 2537.42
Aug 2537.42
Aug 2535.74
Aug 2537.42
Aug 2537.42
Jul 2535.74
Jul 2535.74
Jul 2535.74
Jul 2535.74
Price/Operating Cashflow
0255075100med 3.05Jan 25Feb 25Jul 25Aug 25Oct 25Nov 25Dec 25
APLI.TO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 253.05
Dec 252.44
Dec 253.05
Dec 253.05
Nov 253.05
Nov 253.05
Nov 253.05
Nov 253.05
Oct 253.05
Oct 253.66
Oct 253.66
Oct 253.05
Oct 253.66
Sep 252.79
Sep 252.09
Sep 252.09
Sep 252.09
Aug 252.79
Aug 252.79
Aug 252.09
Aug 252.79
Aug 252.79
Jul 252.09
Jul 252.09
Jul 252.09
Jul 252.09
Mar 2585.9
Mar 2575.16
Mar 2564.42
Mar 2575.16
Feb 2575.16
Feb 2564.42
Feb 2564.42
Feb 2575.16
Jan 2575.16
Jan 2564.42
Jan 2575.16
Jan 2575.16
Jan 2575.16
Price to Book
0255075100med 3.81Apr 20Jul 20Oct 20Feb 21May 21Sep 21Dec 21
APLI.TO Price to Book by quarter
PeriodPrice to Book
Dec 211.31
Dec 211.07
Dec 211.29
Dec 211.45
Nov 211.71
Nov 211.98
Nov 212.73
Nov 218.14
Oct 218.25
Oct 218.14
Oct 217.5
Oct 218.04
Oct 2110.82
Sep 214.66
Sep 214.71
Sep 214.27
Sep 214.27
Aug 213.73
Aug 213.78
Aug 213.44
Aug 213.63
Jul 213.98
Jul 213.49
Jul 213.44
Jul 213.44
Jul 213.49
Jun 212.65
Jun 212.76
Jun 213.04
Jun 213.04
May 213.08
May 213.01
May 214.12
May 214.48
Apr 214.23
Apr 213.58
Apr 213.76
Apr 213.72
Apr 213.83
Mar 212.93
Mar 212.93
Mar 213.02
Mar 212.81
Feb 213.13
Feb 213.51
Feb 213.87
Feb 213.4
Jan 212.93
Jan 213.31
Jan 213.28
Jan 213.4
Dec 203.57
Dec 202.63
Dec 202.8
Dec 202.76
Dec 202.67
Nov 202.76
Nov 202.5
Nov 202.65
Nov 203.44
Oct 203.2
Oct 203.07
Oct 203.2
Oct 203.15
Oct 203.26
Sep 205.51
Sep 205.29
Sep 204.8
Sep 204.13
Aug 203.42
Aug 204.13
Aug 204.18
Aug 204.13
Jul 204.13
Jul 204.31
Jul 204.62
Jul 205.02
Jul 204.36
Jun 2044.6
Jun 2046.89
Jun 2050.57
Jun 2051.95
May 2070.34
May 2077.7
May 2083.21
May 2068.5
May 2071.26
Apr 2062.07
Apr 2050.57
Apr 2044.14
Apr 2036.78
Mar 2012.73
Mar 2012.19
Mar 209.64
Mar 2010.91
Feb 2012.55
Feb 2014.37
Feb 2014.37
Feb 2016.37
Jan 2017.46
Appili Therapeutics Inc.
APLI.TO
Stockpicker

Video analysis: APLI.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.